{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:29:07Z","timestamp":1790908147908,"version":"4.1.0"},"reference-count":59,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,12,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We show the molecular and functional characterization of a novel population of lineage-negative CD34-negative (Lin\u2212CD34\u2212) hematopoietic stem cells from chronic myelogenous leukemia (CML) patients at diagnosis. Molecular karyotyping and quantitative analysis of BCR-ABL transcript demonstrated that approximately one-third of CD34\u2212 cells are leukemic. CML Lin\u2212CD34\u2212 cells showed kinetic quiescence and limited clonogenic capacity. However, stroma-dependent cultures induced CD34 expression on some cells and cell cycling, and increased clonogenic activity and expression of BCR-ABL transcript. Lin\u2212CD34\u2212 cells showed hematopoietic cell engraftment rate in 2 immunodeficient mouse strains similar to Lin-CD34+ cells, whereas endothelial cell engraftment was significantly higher. Gene expression profiling revealed the down-regulation of cell-cycle arrest genes and genes involved in antigen presentation and processing, while the expression of genes related to tumor progression, such as angiogenic factors, was strongly up-regulated compared with normal counterparts. Phenotypic analysis confirmed the significant down-regulation of HLA class I and II molecules in CML Lin\u2212CD34\u2212 cells. Imatinib mesylate did not reduce fusion transcript levels, BCR-ABL kinase activity, and clonogenic efficiency of CML Lin\u2212CD34\u2212 cells in vitro. Moreover, leukemic CD34\u2212 cells survived exposure to BCR-ABL inhibitors in vivo. Thus, we identified a novel CD34\u2212 leukemic stem cell subset in CML with peculiar molecular and functional characteristics.<\/jats:p>","DOI":"10.1182\/blood-2008-08-176016","type":"journal-article","created":{"date-parts":[[2009,10,23]],"date-time":"2009-10-23T21:29:42Z","timestamp":1256333382000},"page":"5191-5200","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":57,"title":["Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34\u2212 cell population with intrinsic resistance to imatinib"],"prefix":"10.1182","volume":"114","author":[{"given":"Roberto M.","family":"Lemoli","sequence":"first","affiliation":[{"name":"Institute of Hematology and Medical Oncology L & A Ser\u00e0gnoli, University of Bologna, Bologna, and Stem Cell Research Center, S Orsola-Malpighi Hospital, Bologna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Salvestrini","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Medical Oncology L & A Ser\u00e0gnoli, University of Bologna, Bologna, and Stem Cell Research Center, S Orsola-Malpighi Hospital, Bologna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Section of Biochemistry, University of Modena and Reggio Emilia, Modena;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertolini","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology-Oncology, Departments of Pathology and Medicine, European Institute of Oncology, Milan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Fogli","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Medical Oncology L & A Ser\u00e0gnoli, University of Bologna, Bologna, and Stem Cell Research Center, S Orsola-Malpighi Hospital, Bologna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilina","family":"Amabile","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Medical Oncology L & A Ser\u00e0gnoli, University of Bologna, Bologna, and Stem Cell Research Center, S Orsola-Malpighi Hospital, Bologna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Tafuri","sequence":"additional","affiliation":[{"name":"Department of Cellular Biotechnology and Hematology, Section of Hematology, La Sapienza University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Salati","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Section of Biochemistry, University of Modena and Reggio Emilia, Modena;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Zini","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Section of Biochemistry, University of Modena and Reggio Emilia, Modena;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Testoni","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Medical Oncology L & A Ser\u00e0gnoli, University of Bologna, Bologna, and Stem Cell Research Center, S Orsola-Malpighi Hospital, Bologna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Rabascio","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology-Oncology, Departments of Pathology and Medicine, European Institute of Oncology, Milan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Rossi","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Medical Oncology L & A Ser\u00e0gnoli, University of Bologna, Bologna, and Stem Cell Research Center, S Orsola-Malpighi Hospital, Bologna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Martin-Padura","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology-Oncology, Departments of Pathology and Medicine, European Institute of Oncology, Milan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Castagnetti","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Medical Oncology L & A Ser\u00e0gnoli, University of Bologna, Bologna, and Stem Cell Research Center, S Orsola-Malpighi Hospital, Bologna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Marighetti","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology-Oncology, Departments of Pathology and Medicine, European Institute of Oncology, Milan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinelli","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Medical Oncology L & A Ser\u00e0gnoli, University of Bologna, Bologna, and Stem Cell Research Center, S Orsola-Malpighi Hospital, Bologna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Baccarani","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Medical Oncology L & A Ser\u00e0gnoli, University of Bologna, Bologna, and Stem Cell Research Center, S Orsola-Malpighi Hospital, Bologna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Section of Biochemistry, University of Modena and Reggio Emilia, Modena;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Manfredini","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Section of Biochemistry, University of Modena and Reggio Emilia, Modena;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"8","key":"2019111723245012000_B1","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood.V94.8.2548.420k38_2548_2554","article-title":"Reversible expression of CD34 by murine hematopoietic stem cells.","volume":"94","author":"Sato","year":"1999","journal-title":"Blood"},{"issue":"5","key":"2019111723245012000_B2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0301-472X(03)00051-1","article-title":"Reversible expression of CD34 by adult human bone marrow long-term engrafting hematopoietic stem cells.","volume":"31","author":"Zanjani","year":"2003","journal-title":"Exp Hematol"},{"issue":"1","key":"2019111723245012000_B3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2002-01-0025","article-title":"Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution.","volume":"101","author":"Dao","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2019111723245012000_B4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1046\/j.1365-2141.2003.04673.x","article-title":"Functional and kinetic characterization of granulocyte colony-stimulating factor-primed CD34- human stem cells.","volume":"123","author":"Lemoli","year":"2003","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111723245012000_B5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1634\/stemcells.2004-0265","article-title":"The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment.","volume":"23","author":"Manfredini","year":"2005","journal-title":"Stem Cells"},{"issue":"15","key":"2019111723245012000_B6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia\u2013advances in biology and new approaches to treatment.","volume":"349","author":"Goldman","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111723245012000_B7","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","article-title":"Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia.","volume":"94","author":"Holyoake","year":"1999","journal-title":"Blood"},{"issue":"3","key":"2019111723245012000_B8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.leu.2403649","article-title":"Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.","volume":"19","author":"Eisterer","year":"2005","journal-title":"Leukemia"},{"issue":"12","key":"2019111723245012000_B9","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1634\/stemcells.2007-0250","article-title":"Transcriptional analysis of quiescent and proliferating CD34+ human hemopoietic cells from normal and chronic myeloid leukemia sources.","volume":"25","author":"Graham","year":"2007","journal-title":"Stem Cells"},{"issue":"1","key":"2019111723245012000_B10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro.","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"issue":"11","key":"2019111723245012000_B11","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction.","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"issue":"9","key":"2019111723245012000_B12","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1182\/blood-2006-11-057521","article-title":"Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells.","volume":"109","author":"J\u00f8rgensen","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2019111723245012000_B13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2404609","article-title":"Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies.","volume":"21","author":"Jiang","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"2019111723245012000_B14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-2141.1998.00659.x","article-title":"Selective expansion of normal haemopoietic progenitors from chronic myelogenous leukaemia marrow.","volume":"101","author":"Fogli","year":"1998","journal-title":"Br J Haematol"},{"issue":"12","key":"2019111723245012000_B15","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1038\/sj.leu.2401595","article-title":"Rapid and sensitive detection of all types of MLL gene translocations with a single FISH probe set.","volume":"13","author":"van der Burg","year":"1999","journal-title":"Leukemia"},{"issue":"1\u20132","key":"2019111723245012000_B16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/10428190009053544","article-title":"Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response.","volume":"39","author":"Martinelli","year":"2000","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"2019111723245012000_B17","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u201creal-time\u201d quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia: a Europe Against Cancer program.","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"issue":"10","key":"2019111723245012000_B18","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1182\/blood.V95.10.3102","article-title":"beta2 microglobulin-deficient (B2m(null)) NOD\/SCID mice are excellent recipients for studying human stem cell function.","volume":"95","author":"Kollet","year":"2000","journal-title":"Blood"},{"issue":"11","key":"2019111723245012000_B19","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nbt1350","article-title":"Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.","volume":"25","author":"Ishikawa","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"9","key":"2019111723245012000_B20","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/ijc.23772","article-title":"Human acute leukemia cells injected in NOD\/LtSz-scid\/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD\/scid-related strains.","volume":"123","author":"Agliano","year":"2008","journal-title":"Int J Cancer"},{"issue":"12","key":"2019111723245012000_B21","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1158\/0008-5472.CAN-04-0265","article-title":"Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells.","volume":"64","author":"Rabascio","year":"2004","journal-title":"Cancer Res"},{"issue":"3","key":"2019111723245012000_B22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/sj.leu.2404549","article-title":"Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.","volume":"21","author":"Diaz-Blanco","year":"2007","journal-title":"Leukemia"},{"issue":"34","key":"2019111723245012000_B23","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1038\/sj.onc.1208596","article-title":"Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia.","volume":"24","author":"Kronenwett","year":"2005","journal-title":"Oncogene"},{"issue":"5","key":"2019111723245012000_B24","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/leu.2008.392","article-title":"The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence.","volume":"23","author":"Bruns","year":"2009","journal-title":"Leukemia"},{"issue":"25","key":"2019111723245012000_B25","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1038\/sj.onc.1206620","article-title":"Chronic myelogenous leukemia molecular signature.","volume":"22","author":"Nowicki","year":"2003","journal-title":"Oncogene"},{"issue":"4","key":"2019111723245012000_B26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00282-996-0313-4","article-title":"Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies.","volume":"38","author":"Baghdassarian","year":"1996","journal-title":"Hematol Cell Ther"},{"issue":"1","key":"2019111723245012000_B27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jcp.10212","article-title":"Putative role for EPC-1\/PEDF in the G0 growth arrest of human diploid fibroblasts.","volume":"195","author":"Pignolo","year":"2003","journal-title":"J Cell Physiol"},{"issue":"3","key":"2019111723245012000_B28","first-page":"471","article-title":"Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts.","volume":"12","author":"Goruppi","year":"1996","journal-title":"Oncogene"},{"issue":"2","key":"2019111723245012000_B29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/dna.1994.13.125","article-title":"A human gene encoding a putative basic helix-loop-helix phosphoprotein whose mRNA increases rapidly in cycloheximide-treated blood mononuclear cells.","volume":"13","author":"Siderovski","year":"1994","journal-title":"DNA Cell Biol"},{"issue":"23","key":"2019111723245012000_B30","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1038\/sj.onc.1206418","article-title":"A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA.","volume":"22","author":"Stoecklin","year":"2003","journal-title":"Oncogene"},{"issue":"18","key":"2019111723245012000_B31","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1038\/sj.onc.1205384","article-title":"MBP-1 mediated apoptosis involves cytochrome c release from mitochondria.","volume":"21","author":"Ghosh","year":"2002","journal-title":"Oncogene"},{"issue":"24","key":"2019111723245012000_B32","doi-asserted-by":"crossref","first-page":"10051","DOI":"10.1073\/pnas.0700007104","article-title":"Inhibition of ubiquitin-mediated degradation of MOAP-1 by apoptotic stimuli promotes Bax function in mitochondria.","volume":"104","author":"Fu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111723245012000_B33","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.cdd.4401987","article-title":"BCL2 family in DNA damage and cell cycle control.","volume":"13","author":"Zinkel","year":"2006","journal-title":"Cell Death Differ"},{"issue":"10","key":"2019111723245012000_B34","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3324\/haematol.11472","article-title":"Eosinophils, but not neutrophils, exhibit an efficient DNA repair machinery and high nucleolar activity.","volume":"92","author":"Salati","year":"2007","journal-title":"Haematologica"},{"issue":"2","key":"2019111723245012000_B35","first-page":"173","article-title":"BCR\/ABL-mediated increased expression of multiple known and novel genes that may contribute to the pathogenesis of chronic myelogenous leukemia.","volume":"2","author":"Salesse","year":"2003","journal-title":"Mol Cancer Ther"},{"issue":"57","key":"2019111723245012000_B36","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.1038\/sj.onc.1205029","article-title":"Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells.","volume":"20","author":"Ohmine","year":"2001","journal-title":"Oncogene"},{"issue":"11","key":"2019111723245012000_B37","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.RES.0000102937.50486.1B","article-title":"Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1.","volume":"93","author":"Kelly","year":"2003","journal-title":"Circ Res"},{"issue":"12","key":"2019111723245012000_B38","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1349-7006.2003.tb01397.x","article-title":"Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor.","volume":"94","author":"Okuda","year":"2003","journal-title":"Cancer Sci"},{"issue":"2","key":"2019111723245012000_B39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2008.03.018","article-title":"The inflammatory chemokines CCL2 and CCL5 in breast cancer.","volume":"267","author":"Soria","year":"2008","journal-title":"Cancer Lett"},{"issue":"2","key":"2019111723245012000_B40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1152\/physiolgenomics.00045.2008","article-title":"Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome.","volume":"34","author":"Roy","year":"2008","journal-title":"Physiol Genomics"},{"issue":"8","key":"2019111723245012000_B41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00251-005-0018-9","article-title":"Analysis of HLA class Ia transcripts in human leukaemias.","volume":"57","author":"Majumder","year":"2005","journal-title":"Immunogenetics"},{"issue":"3","key":"2019111723245012000_B42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.cgt.7700670","article-title":"Role of 4-1BB:4-1BB ligand in cancer immunotherapy.","volume":"11","author":"Cheuk","year":"2004","journal-title":"Cancer Gene Ther"},{"issue":"2","key":"2019111723245012000_B43","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1172\/JCI18452","article-title":"Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions.","volume":"115","author":"Miyazaki","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111723245012000_B44","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1101\/gad.7.6.1097","article-title":"Ectopic expression of a conditional GATA-2\/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner.","volume":"7","author":"Briegel","year":"1993","journal-title":"Genes Dev"},{"issue":"10","key":"2019111723245012000_B45","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1471-4906(03)00241-2","article-title":"Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1.","volume":"24","author":"Raaphorst","year":"2003","journal-title":"Trends Immunol"},{"issue":"8","key":"2019111723245012000_B46","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1172\/JCI31666","article-title":"Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy.","volume":"117","author":"Aiuti","year":"2007","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111723245012000_B47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.exphem.2007.01.018","article-title":"Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.","volume":"35","author":"Moore","year":"2007","journal-title":"Exp Hematol"},{"issue":"4","key":"2019111723245012000_B48","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.bbrc.2005.10.140","article-title":"Murine mesenchymal and embryonic stem cells express a similar Hox gene profile.","volume":"338","author":"Phinney","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"2019111723245012000_B49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1196\/annals.1349.014","article-title":"Hox genes: from leukemia to hematopoietic stem cell expansion.","volume":"1044","author":"Abramovich","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"2019111723245012000_B50","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1128\/MCB.19.4.3051","article-title":"HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells.","volume":"19","author":"Shen","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"47","key":"2019111723245012000_B51","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1038\/sj.onc.1210764","article-title":"Transcriptional control of granulocyte and monocyte development.","volume":"26","author":"Friedman","year":"2007","journal-title":"Oncogene"},{"key":"2019111723245012000_B52","first-page":"65","article-title":"Abnormalities in the erythroid progenitor compartment in patients with chronic myelogenous leukemia (CML).","volume":"7","author":"Eaves","year":"1979","journal-title":"Exp Hematol"},{"issue":"1","key":"2019111723245012000_B53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","article-title":"Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.","volume":"108","author":"Hughes","year":"2006","journal-title":"Blood"},{"issue":"6","key":"2019111723245012000_B54","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.leu.2404227","article-title":"Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis.","volume":"20","author":"Zheng","year":"2006","journal-title":"Leukemia"},{"issue":"14","key":"2019111723245012000_B55","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1073\/pnas.83.14.5306","article-title":"Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells.","volume":"83","author":"Eaves","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111723245012000_B56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2006.06265.x","article-title":"Impact of BCR\/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.","volume":"135","author":"Primo","year":"2006","journal-title":"Br J Haematol"},{"issue":"7","key":"2019111723245012000_B57","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/blood-2004-07-2514","article-title":"Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics.","volume":"105","author":"Fang","year":"2005","journal-title":"Blood"},{"issue":"9216","key":"2019111723245012000_B58","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0140-6736(00)02241-8","article-title":"Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells.","volume":"355","author":"Gunsilius","year":"2000","journal-title":"Lancet"},{"issue":"9","key":"2019111723245012000_B59","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/79526","article-title":"Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia.","volume":"6","author":"Molldrem","year":"2000","journal-title":"Nat Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/114\/25\/5191\/1320453\/zh805009005191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/114\/25\/5191\/1320453\/zh805009005191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T23:25:10Z","timestamp":1574033110000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/114\/25\/5191\/26515\/Molecular-and-functional-analysis-of-the-stem-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,10]]},"references-count":59,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2009,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-08-176016","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1355990.827093","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,10]]}}}